Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ERK1/2 Antikörper

MAPK1/3 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN966753
  • Target Alle ERK1/2 (MAPK1/3) Antikörper anzeigen
    ERK1/2 (MAPK1/3) (Mitogen-Activated Protein Kinase 1/3 (MAPK1/3))
    Reaktivität
    • 199
    • 170
    • 167
    • 23
    • 23
    • 18
    • 7
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 143
    • 58
    • 4
    Kaninchen
    Klonalität
    • 140
    • 65
    Polyklonal
    Konjugat
    • 99
    • 12
    • 9
    • 9
    • 8
    • 8
    • 8
    • 8
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Dieser ERK1/2 Antikörper ist unkonjugiert
    Applikation
    • 157
    • 65
    • 51
    • 51
    • 50
    • 38
    • 24
    • 23
    • 22
    • 13
    • 7
    • 4
    • 4
    • 3
    • 2
    Immunohistochemistry (IHC)
    Spezifität
    P44/42 MAP Kinase (Ab-204) antibody detects endogenous levels of total p44/42 MAP Kinase protein.
    Aufreinigung
    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
    Immunogen
    The antiserum was produced against synthesized non-phosphopeptide derived from human p44/42 MAP Kinase around the phosphorylation site of tyrosine 204 (T-E-YP-V-A).
    Top Product
    Discover our top product MAPK1/3 Primärantikörper
  • Applikationshinweise
    WB: 1:500~1:1000.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    100ug/100ul.
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Yu, Mizumoto, Tokinaga, Ogawa, Hatano: "The inhibitory effects of sevoflurane on angiotensin II- induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle." in: Anesthesia and analgesia, Vol. 101, Issue 2, pp. 315-21, table of contents, (2005) (PubMed).

    Perez, Nolan: "Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry." in: Nature biotechnology, Vol. 20, Issue 2, pp. 155-62, (2002) (PubMed).

    Ihn, Tamaki: "Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 4, pp. 2149-55, (2000) (PubMed).

    Hannken, Schroeder, Zahner, Stahl, Wolf: "Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells." in: Journal of the American Society of Nephrology : JASN, Vol. 11, Issue 8, pp. 1387-97, (2000) (PubMed).

  • Target
    ERK1/2 (MAPK1/3) (Mitogen-Activated Protein Kinase 1/3 (MAPK1/3))
    Andere Bezeichnung
    p44/42 MAP Kinase (MAPK1/3 Produkte)
    Synonyme
    erk1/2 antikoerper, mitogen-activated protein kinase antikoerper, erk1/2 antikoerper
Sie sind hier:
Kundenservice